Based on an interview done at BIO-Europe, Dicot Pharma CEO Elin Trampe talked to Pharma Vanguard about how erectile dysfunction is no longer important within the realms of just sexual health, but has been established as an indicator within the field of longevity. 

Read the full interview here.